By staying proactive and patient-centric, providers can help patients continue their weight-loss journey safely and effectively. Patients may feel frustrated, confused or anxious about losing access to medications that were working for them
Compounded formulations allow customized dosing protocols tailored to individual weight loss responses and tolerability, which can optimize clinical outcomes
However, this same mechanism may contribute to gastrointestinal side effects, which are among the most commonly reported adverse reactions with GLP-1 therapy
these medications are a combination of GLP-1 plus gastric inhibitory polypeptide agonist (GIP) Semaglutide and tirzepatide are marketed for Type 2 diabetes and weight management under different brand names
Healthcare providers may recommend blood tests to check hormone levels if you experience significant menstrual changes while taking semaglutide
Associations of semaglutide with incidence and recurrence of alcohol use disorder